Bericht
Access to Hepatitis C treatment: A global problem
"Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and development priority until recently". - WHO, Global Health Sector strategy on viral Hepatitis 2016-2021: Towards ending viral hepatitis. This document will address five items: 1) General context and background on the debate over access to medicines. 2) The problem of the Hepatitis C virus (HCV): Figures and data. 3) Access to new direct-acting antiviral (DAA) treatments for Hepatitis C. 4) How to overcome barriers to access: using the flexibilities of the TRIPS Agreement. 5) Some examples of countries that have launched the new HCV treatment and Conclusions.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 77
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Infektionskrankheit
Gesundheitsversorgung
Arzneimittel
Arzneimittelrecht
Internationales Recht
Welt
- Event
-
Geistige Schöpfung
- (who)
-
Velásquez, Germán
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2017
- Handle
- Last update
-
10.03.2025, 11:43 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Velásquez, Germán
- South Centre
Time of origin
- 2017
Other Objects (12)
Equitable access to COVID-19 related health technologies: A global priority
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Intellectual property and access to science
Guidelines on patentability and access to medicines
Intellectual property, public health and access to medicines in international organizations
Restructuring the global vaccine industry
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Second medical use patents: Legal treatment and public health issues
The intersection between intellectual property, public health and access to climate-related technologies
Access to medicines and intellectual property: The contribution of the World Health Organization
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
Equitable access to COVID-19 related health technologies: A global priority
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Intellectual property and access to science
Guidelines on patentability and access to medicines
Intellectual property, public health and access to medicines in international organizations
Restructuring the global vaccine industry
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Second medical use patents: Legal treatment and public health issues
The intersection between intellectual property, public health and access to climate-related technologies
Access to medicines and intellectual property: The contribution of the World Health Organization
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
Equitable access to COVID-19 related health technologies: A global priority
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Intellectual property and access to science
Guidelines on patentability and access to medicines
Intellectual property, public health and access to medicines in international organizations
Restructuring the global vaccine industry
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Second medical use patents: Legal treatment and public health issues
The intersection between intellectual property, public health and access to climate-related technologies
Access to medicines and intellectual property: The contribution of the World Health Organization
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines